Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
Ton, Van-Khue
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction. [electronic resource] - Clinical Medicine Insights. Cardiology 2014 - 39-44 p. digital
Publication Type: Journal Article; Review
1179-5468
10.4137/CMC.S15719 doi
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction. [electronic resource] - Clinical Medicine Insights. Cardiology 2014 - 39-44 p. digital
Publication Type: Journal Article; Review
1179-5468
10.4137/CMC.S15719 doi